Cargando…

Practical considerations on non-vitamin K oral anticoagulants in patients with high body weight

Detalles Bibliográficos
Autor principal:	Undas, Anetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336816/ https://www.ncbi.nlm.nih.gov/pubmed/27067564 http://dx.doi.org/10.14744/AnatolJCardiol.2016.6970

Ejemplares similares

How to Optimize the Administration of Low-Dose Non-vitamin K Antagonist Oral Anticoagulants in Everyday Practice?
por: Undas, Anetta
Publicado: (2022)

Non-vitamin K antagonist oral anticoagulants in cancer patients with atrial fibrillation
por: Undas, Anetta, et al.
Publicado: (2020)

Non-Vitamin K Oral Anticoagulants in Stroke Patients: Practical Issues
por: Malhotra, Konark, et al.
Publicado: (2017)

Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease
por: Undas, Anetta
Publicado: (2023)

Adverse outcomes in anticoagulated patients undergoing percutaneous left atrial appendage ligation
por: Undas, Anetta
Publicado: (2020)

Antithrombotic management in patients with percutaneous coronary intervention requiring oral anticoagulation
por: Zalewski, Jarosław, et al.
Publicado: (2016)

How to improve the management of a patient with heparin-induced thrombocytopenia?
por: Undas, Anetta
Publicado: (2019)

Consideration of NOACs (novel or non-vitamin K-dependent oral anticoagulants) in dental procedure
por: Song, Jiyoung
Publicado: (2021)

Paradoxical Procoagulant Effect of Early Doses of Warfarin: Possible Role of Non-Vitamin K Oral Anticoagulant in Patients with Atrial Fibrillation-Related Stroke
por: Kim, Yesel, et al.
Publicado: (2015)

Anticoagulant Treatment in Patients with Atrial Fibrillation and Chronic Kidney Disease: Practical Issues
por: Matusik, Paweł T., et al.
Publicado: (2022)

Non-Vitamin K Oral Anticoagulants in Stroke Patients: Practical Issues
por: Diener, Hans-Christoph, et al.
Publicado: (2016)

Unexplained thrombosis of the aortic arch with distal embolization in a patient with altered fibrin clot properties
por: Ciurus, Tomasz, et al.
Publicado: (2012)

Practical and clinical considerations in assessing patients with atrial fibrillation for switching to non-vitamin K antagonist oral anticoagulants in primary care
por: Guimarães, Patrícia O, et al.
Publicado: (2015)

Factors Influencing Oral Anticoagulant Prescribing Practices for Atrial Fibrillation
por: Leung, Lester Y., et al.
Publicado: (2017)

Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)

Off‐target effects of oral anticoagulants – vascular effects of vitamin K antagonist and non‐vitamin K antagonist oral anticoagulant dabigatran etexilate
por: van Gorp, Rick H., et al.
Publicado: (2021)

Evidence Gaps in the Era of Non–Vitamin K Oral Anticoagulants
por: Aronis, Konstantinos N., et al.
Publicado: (2018)

An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants
por: Mujer, Mark Terence P., et al.
Publicado: (2020)

Special considerations for therapeutic choice of non–vitamin K antagonist oral anticoagulants for Japanese patients with nonvalvular atrial fibrillation
por: Okumura, Ken, et al.
Publicado: (2016)

Effectiveness and safety of non-vitamin K antagonist oral anticoagulant in the treatment of patients with morbid obesity or high body weight with venous thromboembolism: A meta-analysis
por: Zhang, Hongxia, et al.
Publicado: (2023)

Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants
por: Garkina, Svetlana V, et al.
Publicado: (2016)

Management of Non-Vitamin K Antagonist Oral Anticoagulants in the Perioperative Setting
por: Dincq, Anne-Sophie, et al.
Publicado: (2014)

Non-Vitamin K Oral Anticoagulants Associated Bleeding and Its Antidotes
por: Steiner, Thorsten, et al.
Publicado: (2018)

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with β-Thalassemia
por: Malagù, Michele, et al.
Publicado: (2023)

Non-vitamin K oral anticoagulant use in the elderly: a prospective real-world study – data from the REGIstry of patients on Non-vitamin K oral Anticoagulants (REGINA)
por: Monelli, Mauro, et al.
Publicado: (2019)

Overcoming barriers to integrating direct oral anticoagulants into existing anticoagulation management services
por: Sylvester, Katelyn W., et al.
Publicado: (2018)

Austrian recommendations for best clinical practice in case of haemorrhagic traumatic brain injury under platelet inhibitors or non-vitamin K antagonist oral anticoagulants: an additional therapeutic option to consider
por: Honore, Patrick M., et al.
Publicado: (2020)

The efficacy and safety of out-hospital anticoagulation therapy with direct oral anticoagulant for COVID-19
por: Geng, Yu, et al.
Publicado: (2023)

Practical Considerations for Use of Direct Oral Anticoagulants in Children
por: Whitworth, Hilary, et al.
Publicado: (2022)

Appropriate Dosing Regimens of Non-Vitamin K Antagonist Oral Anticoagulants for Treatment of Patients With Non-Valvular Atrial Fibrillation: An Evidence-Based Consideration
por: Zhao, Shujuan, et al.
Publicado: (2020)

Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation
por: Peeters, Frederique E. C. M., et al.
Publicado: (2018)

Association of Vitamin K and Non‐Vitamin K Oral Anticoagulant Use and Cancer Incidence in Atrial Fibrillation Patients
por: Iftimi, Adina A., et al.
Publicado: (2021)

Psychological effects of treatment with novel oral anticoagulants in non-valvular atrial fibrillation patients
por: Öncel, Can Ramazan
Publicado: (2016)

Safety and effectiveness of anticoagulation with non-vitamin K antagonist oral anticoagulants and warfarin in patients on tuberculosis treatment
por: Lee, Hyun-Jung, et al.
Publicado: (2023)

Beyond warfarin: The advent of new oral anticoagulants
por: Malhotra, Konark, et al.
Publicado: (2016)

Consideration Needed for early Anticoagulation Following Intravenous tPA in Patients with COVID-19
por: Jimenez, Angelo, et al.
Publicado: (2021)

Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants
por: Faraoni, David, et al.
Publicado: (2015)

Impact of Non-vitamin K Antagonist Oral Anticoagulant Withdrawal on Stroke Outcomes
por: Park, Joong Hyun, et al.
Publicado: (2018)

Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding
por: Gremmel, Thomas, et al.
Publicado: (2018)

Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease
por: Fanaroff, Alexander C, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_996ls9e170k2va5d0oeehgqv3f